A gauge of demand from potential British homeowners climbed to its highest level in six months, a signal that the real estate market is starting to stabilizing from a tax-increase induced slowdown that’s weighed on house prices https://t.co/yzJMMnfDqy ...

Costco Wholesale (COST) 2025 Update Summary Industry Overview - The call pertains to the retail industry, specifically focusing on Costco Wholesale's performance during the five-week retail month of June 2025. Key Financial Metrics - **Net Sales**: Reported net sales for June 2025 were $26.44 billion, representing an 8% increase from $24.48 billion in June 2024 [2] - **Comparable Sales**: - US: 4.7% - Canada: 6.7% - Other International: 10.9% - Total Company: 5.8% - E-commerce: 11.5% [2] - **Comparable Sales Excluding Gas and FX**: - US: 5.5% - Canada: 7.9% - Other International: 8.2% - Total Company: 6.2% - E-commerce: 11.2% [3] Traffic and Transaction Insights - **Traffic Growth**: Comp traffic increased by 3.4% worldwide and 2.8% in the US [4] - **Average Transaction Value**: - Worldwide average transaction value increased by 2.4%, and by 2.8% when excluding gas deflation and foreign exchange impacts [5] Regional Performance - **Strongest US Regions**: Northwest, Midwest, and Southeast showed the best comparable sales performance [5] - **International Performance**: Australia, Mexico, and Taiwan reported the strongest results among other international markets [6] Merchandising Highlights - **Food Categories**: - Foods and sundries showed positive mid-single-digit growth - Fresh foods increased by high single digits, with meat and produce being top performers [6][7] - **Non-food Categories**: - Positive mid to high single-digit growth, with jewelry, majors, and gift cards performing well [7] - **Ancillary Business Sales**: Experienced a decline in low single digits, while pharmacy, hearing aid, and optical departments were top performers [8] External Factors Impacting Sales - **Gas Price Deflation**: Negatively impacted total reported comparable sales by approximately -0.9% [4] - **Foreign Currency Impact**: - Canada: +0.2% - Other International: +3.4% - Total Company: +0.5% [4] Future Outlook - The next reporting period will cover four weeks from July 7 to August 3, 2025, compared to the same period in 2024 [8]

Bitcoin is approaching price discovery.When it breaks, which altcoins will pump the hardest? ...

Key Takeaways CINF benefits from prudent pricing, an agent-centric model, and disciplined growth in Cincinnati Re. CINF actively returns capital, reflecting strong operating performance and financial flexibility. CINF boasts 65 consecutive years of dividend increases, with a current yield surpassing the industry average.Cincinnati Financial Corporation (CINF) has been trading above its 200-day simple moving average (SMA), signaling a short-term bullish trend. Its share price, as of July 8, 2025, was $146. ...

Company Overview - MiMedx (MDXG) shares increased by 8% in the last trading session, closing at $7, with higher trading volume compared to normal sessions [1] - The stock has shown a 0.5% gain over the past four weeks [1] - The rise in stock price is linked to investor optimism regarding the company's product portfolio in wound care, burn, and surgical sectors [1] Financial Performance - MiMedx is expected to report quarterly earnings of $0.06 per share, reflecting a year-over-year decline of 25% [2] - Revenue projections for the upcoming quarter are $89.28 million, which is a 2.4% increase from the same quarter last year [2] Earnings Estimates and Stock Movement - The consensus EPS estimate for MiMedx has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] - Historical data suggests that stock prices typically do not continue to rise without trends in earnings estimate revisions [3][4] Industry Context - MiMedx operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like PTC Therapeutics (PTCT) [5] - PTC Therapeutics has experienced a 0.7% decline in its stock price, with a return of -7.2% over the past month [5] - The consensus EPS estimate for PTC Therapeutics has decreased by 0.4% to -$1.07, representing a 7.8% increase from the previous year [6]

Prolly good time to remind everyone I’m literally just a lion jpeg LARPing as a market/random other topics expert.Pump TGE could go very well. Could also go very poorly.Price action will decide if they were brilliant or idiots. And none of our commentary matters.And the streamers are the huge winners here imo. Very few streamers on platform…with $120m tokens earmarked for them. Gg Eddie/Rasmr/Jakey/Gainzy/etc.Kingmaker airdrop imo for themIcoBeast.eth🦇🔊 (@beast_ico):So *all* tokens unlocked except for a sma ...

Copper Prices Surge To Record High In Largest Increase Since ‘80s—Here’s Why https://t.co/nP9UHkq1O0 https://t.co/XhI82YpDnA ...

Market Overview - The S&P 500 rose by 5% in June, driven by optimism regarding trade deals, a ceasefire in the Middle East, and potential interest rate cuts in 2025 [1] - Positive economic indicators, including strong manufacturing data, increased factory orders, and a favorable jobs report for June, alleviated recession fears [1] July Market Conditions - As July begins, the job market remains robust, inflation is cooling, and companies are set to announce earnings [2] - Trade disagreements may cause short-term market fluctuations, but new trade agreements could provide additional momentum [2] Stock Recommendations - Recommended stocks based on relative price strength include Dell Technologies Inc. (DELL), Jabil Inc. (JBL), Phibro Animal Health Corporation (PAHC), and Hudbay Minerals Inc. (HBM) [3][9] Relative Price Strength Strategy - Investors should assess stocks based on earnings growth and valuation multiples, while also considering their performance relative to industry peers [4] - Underperforming stocks should be avoided, while those outperforming their sectors in price should be prioritized for potential returns [5] Investment Criteria - Stocks that have outperformed the S&P 500 over the past 1, 4, and 12 weeks, along with positive earnings estimate revisions, indicate growth potential [6][8] - A focus on analyst optimism regarding upcoming earnings is crucial, as upward revisions can lead to price gains [7] Screening Parameters - Stocks must show positive relative price changes over 1, 4, and 12 weeks, and have positive current-quarter estimate revisions [8] - Stocks must have a minimum price of $5 and an average 20-day volume of at least 50,000 for adequate liquidity [10] Company Profiles - **Dell Technologies Inc. (DELL)**: Market cap of $84.7 billion, expected EPS growth of 16% year-over-year for fiscal 2026, with a trailing earnings surprise of 2.3% [11][12] - **Jabil Inc. (JBL)**: Expected EPS growth rate of 16.6% over three to five years, with a 102% share price increase in the past year [13][14] - **Phibro Animal Health Corporation (PAHC)**: Market cap of $1.2 billion, expected EPS growth of 71.4% for fiscal 2025, with a 75.7% share price increase in the past year [14][15] - **Hudbay Minerals Inc. (HBM)**: Expected EPS growth rate of 51.7% over three to five years, with a 43.8% year-over-year growth estimate for 2025 and a 17.6% share price increase in the past year [16][17]

LaFleur Minerals Engages Bumigeme to Complete Valuation Report on Beacon Gold Mill July 09, 2025 8:00 AM EDT | Source: LaFleur Minerals Inc. Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - LAFLEUR MINERALS INC. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) ("LaFleur Minerals" or the "Company") is pleased to announce the engagement of Bumigeme Inc., an engineering firm located in the city of Montréal, Québec, specialized in the mining and mineral treatment field, to conduct a valuation report (the "V ...

Look, it is the first meeting of minds since, well, first the Iran Israel war, but then also that Opec+ decision over the weekend to bring back extra barrels to the market. And the feeling is that opec+ have changed their strategy over the last couple of months. Why do you think that is the case. Why do you think they decided to accelerate the pullback.All right. Great to be with you, Jomana. You know, I don't think they've changed their strategy. I think they've doubled down on their strategy.It's clear go ...